MedPath

Three Daily Wear Monthly Replacement Silicone Hydrogel Contact Lenses With Two Multi-purpose Disinfecting Solution Combinations

Not Applicable
Completed
Conditions
Refractive Errors
Registration Number
NCT04789382
Lead Sponsor
Alcon Research
Brief Summary

The purpose of this study is to evaluate corneal staining observed after 2 hours of wear with an investigational contact lens against both PureVision contact lenses pre-cycled with Biotrue and Biofinity contact lenses pre-cycled with RepleniSH.

Detailed Description

Subjects will be randomized in a 1:1:1:1 manner to receive one of 4 regimen sequences with lens and multipurpose disinfection solution (MPDS) combinations. The expected duration of subject participation in the study is approximately 1 week with 2 study visit days.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Understand and sign an Informed Consent;
  • Successful wear of spherical soft contact lenses in both eyes for a minimum of 5 days per week and 8 hours per day during the past 3 months;
  • Manifest cylinder of less than or equal to 1.50 diopter (D) in each eye;
  • Best corrected visual acuity (BCVA) better than or equal to 20/25 Snellen in each eye;
  • Willing to stop wearing habitual contact lenses for the duration of study lens exposure and during the washout period.
  • Other protocol-specified inclusion criteria may apply.

Key

Exclusion Criteria
  • Any eye condition or disease (including systemic) that contraindicates contact lens wear, as determined by the Investigator;
  • Any use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the Investigator;
  • Eye surgery, as specified in the protocol;
  • Dry eye; use of artificial tears, as specified in the protocol;
  • Other protocol-specified exclusion criteria may apply.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Average Percent Area of Corneal StainingHour 2 (each wear period)

A slit lamp examination was performed by the investigator to assess corneal staining. Percent of solution-related corneal staining area was assessed first in each of the 5 corneal regions: central, superior, nasal, inferior, and temporal. The average of corneal staining area was then calculated as the average over all 5 regions. Each eye was treated differently and was graded separately. No hypotheses were formulated; no inferences were made, and only descriptive statistics were used in the reporting.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Alcon Investigator 6565

🇺🇸

Maitland, Florida, United States

Alcon Investigator 6565
🇺🇸Maitland, Florida, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.